Arcxis Biotechnologies is dedicated to the invention, development and distribution of products designed for the preparation of life science samples, subsequent DNA sequence detection and protein measurement. Arcxis’ innovative products deliver to the arena of life sciences (research/clinical and diagnostic) easier, faster and more reliable solutions, providing cost effective analysis.
Arcxis released its’ first product in 2007. This is an automated instrument to co-process multiple samples for the extraction and purification of nucleic acids. Arcxis continues to develop new technologies for sample prep and detection.
Arcxis has recently completed the first close of its Series B round. The funds will enable Arcxis to accelerate development, testing and commercialization of thier innovative nucleic acid sample preparation platform and their nxt generation sample to answer clinical molecular diagnostic platform. Additionally, Arcxis has been awarded Phase I and II awards from the Department of Homeland Security for its development of the BioPhalanx.
No comments:
Post a Comment